Fundraising Fox
Revealix
Techstars '19Austin, US · 1 employees on LinkedIn · 1 known investors
Find your way into Revealix
Sign up to see every warm intro you have to Revealix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Revealix team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Revealix is a clinical decision support platform for diabetic foot health risk assessment that enables healthcare providers to screen, document, and stratify patient risk in a 3-minute mobile workflow. The platform is designed to help intercept foot wound risk in primary care settings before wounds develop, addressing preventable complications in people with diabetes.
Also known as Revealix
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Revealix is a digital health company building what it describes as risk infrastructure for diabetic foot health. Its clinical decision support platform structures the diabetic foot examination into a guided four-step workflow — screen, document, stratify, act — that can be completed in under three minutes on a mobile device by any designated member of the care team. The assessment produces structured clinical documentation with guideline-aligned risk categories and care pathway guidance, rather than free-text notes, and generates personalized patient education and self-monitoring guidance intended to support engagement between visits.
The company frames the problem in four layers: foot checks that are manual, subjective and time-intensive; findings that are untagged and unsearchable in the EHR; patients who leave visits without understanding their risk; and health-plan costs that are invisible until complications occur. At the population level, the platform aggregates risk stratification data so health systems and payers can see where risk concentrates and intervene earlier. The company positions the product as upstream of wound care and remote patient monitoring, targeting risk identification before ulcers develop. Revealix states it is HIPAA-ready and that the product was designed by a clinician experienced in the workflow.
Founding story
Revealix was founded by Adrianna Cantu, who has clinical and operational expertise in wound care and in the factors leading to limb loss. The company describes starting from the question of whether proactive foot screening could be made easy enough that doing the right thing becomes the easy thing, after decades of experience with limb-salvage efforts at the last mile of care.
Business model
Revealix offers a cloud-based mobile software-as-a-service application for healthcare providers and organizations; the website markets the platform to providers, health systems and community health organizations, and health plans and employers, with the product described by a vendor as a commercial SaaS application moving from beta into production.
Traction
The company was preparing a commercial-grade release of its application after a beta stage, and its site collects waitlist registrations; no customer counts or revenue figures are disclosed.
▸Full profile — market position, technology, go-to-market, history, risks & controversies
Market position
Revealix positions itself upstream of existing diabetic foot solutions, which it characterizes as focused on wounds that already exist or on remote monitoring of patients already known to be high risk, whereas its platform is intended to identify risk before wounds develop.
Differentiators cited by the company include a three-minute structured assessment that adds no charting burden, guideline-aligned and consistent risk classification, automated documentation suitable for billing and quality reporting, usability in any care setting including the patient's home, an upstream prevention focus, and HIPAA readiness.
Technology
A mobile-first, cloud-based application that converts a foot health examination into structured, codified risk data and automated clinical notes usable for care coordination, quality reporting and billing. The application runs on AWS, using Docker for container management and provisioning, with infrastructure-as-code deployment via Terraform; the company engaged Growth Acceleration Partners to build scalable, fault-tolerant development, staging and production environments.
Go-to-market
The website invites prospective users to join a waitlist and addresses three buyer segments — individual providers, health systems and community health organizations, and health plans and employers — with testimonials from a podiatrist and public health specialist and from a payer chief medical officer.
Providers across physical therapy, primary care, podiatry and specialist settings; health systems and community health centers seeking standardized screening across sites; and health plans and employers seeking population-level foot health risk intelligence and automated quality-measure documentation.
History
The company developed a cloud-based mobile application and subsequently worked with Growth Acceleration Partners to move that application from beta toward commercial production, rebuilding its AWS infrastructure for scalability and fault tolerance after internal attempts using CloudFormation and AWS CDK proved difficult. As of the current website, Revealix is collecting waitlist signups.
Risks & controversies
The product is described as HIPAA-ready and is a clinical decision support tool handling patient health data, an area subject to healthcare privacy and clinical documentation requirements.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsRevealix worked with Growth Acceleration Partners to design and provision scalable, fault-tolerant AWS development, staging and production environments as it moved its cloud-based mobile application from beta to commercial production, using Docker and Terraform.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 3
primary sources listed
- Revealixrevealix.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Revealix do?
- Revealix is a clinical decision support platform for diabetic foot health risk screening in a 3-minute mobile workflow.
- Who are Revealix's investors?
- Revealix's investors include Techstars.
- Where is Revealix headquartered?
- Revealix is headquartered in Austin, US.